| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Mark Lathrop | Q6768494 |
| Moisés Selman | Q87622005 | ||
| Annie Pardo Cemo | Q87622008 | ||
| Yoichiro Kamatani | Q88032943 | ||
| Tasha E Fingerlin | Q89288019 | ||
| Kevin F Gibson | Q124694079 | ||
| Janet Talbert | Q125264091 | ||
| Steve Groshong | Q125264382 | ||
| Diana Zelenika | Q30248012 | ||
| Naftali Kaminski | Q41048454 | ||
| Miriam F Moffatt | Q56959224 | ||
| P2093 | author name string | David A. Schwartz | |
| Dong Soon Kim | |||
| Karl Kossen | |||
| David Lynch | |||
| Keith Smith | |||
| Yingze Zhang | |||
| Anna L. Peljto | |||
| Athol U. Wells | |||
| Barry J. Make | |||
| Brent S. Pedersen | |||
| Cheryl R. Markin | |||
| Christine Kim Garcia | |||
| David McKean | |||
| Dinesha S. Walek | |||
| Elissa Murphy | |||
| Elizabeth A. Regan | |||
| Gregory P. Cosgrove | |||
| Gunnar Gudmundsson | |||
| Harold R. Collard | |||
| Helgi J. Isaksson | |||
| James D. Crapo | |||
| James E. Loyd | |||
| Jerry J. Daniel | |||
| Joy D. Cogan | |||
| Kenneth B. Beckman | |||
| Kevin K. Brown | |||
| Lisa H. Lancaster | |||
| Mark P. Steele | |||
| Marvin I. Schwarz | |||
| Megan S. Devine | |||
| Paul J. Wolters | |||
| Philip L. Molyneaux | |||
| Raven N. Kidd | |||
| Roland M. du Bois | |||
| Scott D. Seiwert | |||
| Toby M. Maher | |||
| Weiming Zhang | |||
| Wendi R. Mason | |||
| Williamson Z. Bradford | |||
| P2860 | cites work | Usual interstitial pneumonia in an adolescent with ABCA3 mutations | Q81643537 |
| Spi-1/PU.1 oncoprotein affects splicing decisions in a promoter binding-dependent manner | Q83337192 | ||
| Idiopathic pulmonary fibrosis--a sticky business | Q83910473 | ||
| Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012 | Q84819949 | ||
| A flexible and accurate genotype imputation method for the next generation of genome-wide association studies | Q21129496 | ||
| Population structure and eigenanalysis | Q21145248 | ||
| Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma | Q22008664 | ||
| alphaT-catenin: a novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion | Q24291766 | ||
| Hedgehog signaling pathway and gastric cancer | Q24293156 | ||
| Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q24300083 | ||
| Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci | Q24306903 | ||
| Genotype imputation with thousands of genomes | Q24633967 | ||
| The desmosome | Q24656653 | ||
| Striate palmoplantar keratoderma resulting from desmoplakin haploinsufficiency | Q28140124 | ||
| Compound heterozygosity for non-sense and mis-sense mutations in desmoplakin underlies skin fragility/woolly hair syndrome | Q28200853 | ||
| DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis | Q28240199 | ||
| Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial | Q28250518 | ||
| Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q28274829 | ||
| Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis | Q28283421 | ||
| A novel gene family encoding leucine-rich repeat transmembrane proteins differentially expressed in the nervous system | Q28511734 | ||
| A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis | Q29417118 | ||
| A new multipoint method for genome-wide association studies by imputation of genotypes | Q29547209 | ||
| GCTA: a tool for genome-wide complex trait analysis | Q29547216 | ||
| METAL: fast and efficient meta-analysis of genomewide association scans | Q29547217 | ||
| LocusZoom: regional visualization of genome-wide association scan results | Q29614868 | ||
| Genotype imputation for genome-wide association studies | Q29614880 | ||
| Rare variants create synthetic genome-wide associations | Q29614955 | ||
| Telomerase mutations in families with idiopathic pulmonary fibrosis | Q29615671 | ||
| Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. | Q30374030 | ||
| Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. | Q30427183 | ||
| ??? | Q28215495 | ||
| Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis | Q30484036 | ||
| Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? | Q30841647 | ||
| Structural haplotypes and recent evolution of the human 17q21.31 region | Q33608188 | ||
| Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
| Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology | Q33927045 | ||
| Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis | Q34069594 | ||
| Genetic epidemiology of COPD (COPDGene) study design | Q34074731 | ||
| A linear complexity phasing method for thousands of genomes | Q34237936 | ||
| ABCA3 gene mutations in newborns with fatal surfactant deficiency | Q34308818 | ||
| ABCA3 mutations associated with pediatric interstitial lung disease | Q34455684 | ||
| A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis | Q35083039 | ||
| Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF | Q35536294 | ||
| Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis | Q35749152 | ||
| Adult-onset pulmonary fibrosis caused by mutations in telomerase | Q35759839 | ||
| A common MUC5B promoter polymorphism and pulmonary fibrosis. | Q36048530 | ||
| Structural diversity and African origin of the 17q21.31 inversion polymorphism | Q36129488 | ||
| Clinical and pathologic features of familial interstitial pneumonia | Q36234581 | ||
| Respiratory tract mucin genes and mucin glycoproteins in health and disease | Q36350071 | ||
| Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans | Q36435865 | ||
| Short telomeres are a risk factor for idiopathic pulmonary fibrosis | Q36861819 | ||
| Novel homozygous mutation in DSP causing skin fragility-woolly hair syndrome: report of a large family and review of the desmoplakin-related phenotypes | Q37782390 | ||
| Synthetic associations in the context of genome-wide association scan signals | Q37784094 | ||
| Pathobiology of pulmonary fibrosis | Q37972597 | ||
| Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer. | Q39315240 | ||
| Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis | Q40334332 | ||
| Genome-wide efficient mixed-model analysis for association studies | Q41961596 | ||
| An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis | Q42496001 | ||
| Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred | Q42675595 | ||
| Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a | Q42742534 | ||
| Investigation of the fine structure of European populations with applications to disease association studies | Q44199896 | ||
| Improved whole-chromosome phasing for disease and population genetic studies | Q44584387 | ||
| Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study. | Q50900397 | ||
| Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. | Q54418482 | ||
| Idiopathic Pulmonary Fibrosis | Q56804123 | ||
| P4510 | describes a project that uses | genome-wide association study | Q1098876 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| genome-wide association study | Q1098876 | ||
| susceptibility locus | Q62091149 | ||
| P304 | page(s) | 613–620 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis | |
| P478 | volume | 45 |
| Q41034398 | 13th ERS Lung Science Conference. The most important take home messages: News from the Underground |
| Q37213583 | A Chronic Obstructive Pulmonary Disease Susceptibility Gene, FAM13A, Regulates Protein Stability of β-Catenin |
| Q42228778 | A Dataset of 26 Candidate Gene and Pro-Inflammatory Cytokine Variants for Association Studies in Idiopathic Pulmonary Fibrosis: Frequency Distribution in Normal Czech Population |
| Q43062900 | A Phenome-Wide Association Study Identifies a Novel Asthma Risk Locus Near TERC. |
| Q58714376 | A Rare Missense Variant in Telomerase Reverse Transcriptase is Associated with Idiopathic Pulmonary Fibrosis in a Chinese Han Family |
| Q35826595 | A comparison of visual and quantitative methods to identify interstitial lung abnormalities |
| Q43178545 | A first glimpse at the early origins of idiopathic pulmonary fibrosis |
| Q42704966 | A genome-wide association study identifies susceptibility loci of silica-related pneumoconiosis in Han Chinese |
| Q37652005 | A genome-wide association study yields five novel thyroid cancer risk loci |
| Q35177444 | A genome-wide pleiotropy scan for prostate cancer risk |
| Q42378561 | A global perspective of lung transplantation: Part 1 - Recipient selection and choice of procedure |
| Q30578066 | A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant |
| Q38450487 | A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis |
| Q64063038 | A novel germline mutation of the gene in familial interstitial pneumonia |
| Q27014138 | A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease |
| Q47563113 | AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease |
| Q38846300 | Alveolar epithelial disintegrity in pulmonary fibrosis. |
| Q39014952 | An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis |
| Q47213836 | An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. |
| Q33734193 | Analysis of Microarray-Identified Genes and MicroRNAs Associated with Idiopathic Pulmonary Fibrosis |
| Q35819457 | Analysis of heat shock protein 70 gene polymorphisms Mexican patients with idiopathic pulmonary fibrosis |
| Q89067942 | Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study |
| Q50077754 | Another building in the IPF Manhattan plot skyline. |
| Q64916149 | Application of Isobaric Tags for Relative and Absolute Quantification (iTRAQ) Coupled with Two-Dimensional Liquid Chromatography/Tandem Mass Spectrometry in Quantitative Proteomic Analysis for Discovery of Serum Biomarkers for Idiopathic Pulmonary F |
| Q90051408 | Assessing thyroid cancer risk using polygenic risk scores |
| Q30253080 | Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study |
| Q37149994 | Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations |
| Q37081313 | Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations |
| Q91605838 | Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility |
| Q41437838 | Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes |
| Q36464726 | Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis |
| Q90654792 | Association between Telomere-Related Polymorphisms and the Risk of IPF and COPD as a Precursor Lesion of Lung Cancer: Findings from the Fukuoka Tobacco-Related Lung Disease (FOLD) Registry |
| Q28291143 | Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis |
| Q53286287 | Association of lung function genes with chronic obstructive pulmonary disease. |
| Q92483181 | Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis |
| Q36105254 | BARD1 mediates TGF-β signaling in pulmonary fibrosis. |
| Q38833878 | Basal cells of the human airways acquire mesenchymal traits in idiopathic pulmonary fibrosis and in culture |
| Q64262272 | Bioinformatic analysis of next‑generation sequencing data to identify dysregulated genes in fibroblasts of idiopathic pulmonary fibrosis |
| Q37094624 | CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism |
| Q35041517 | CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis |
| Q26777324 | Candidate genes for COPD: current evidence and research |
| Q26764812 | Candidate genes of idiopathic pulmonary fibrosis: current evidence and research |
| Q38399493 | Characteristic patterns in the fibrotic lung. Comparing idiopathic pulmonary fibrosis with chronic lung allograft dysfunction |
| Q35942991 | Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells. |
| Q54213046 | Clinical Genetics in Interstitial Lung Disease. |
| Q89344465 | Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis |
| Q47655004 | Comparative RNA-Seq transcriptome analysis on silica induced pulmonary inflammation and fibrosis in mice silicosis model |
| Q26864326 | Complex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencing |
| Q93216677 | Conditional deletion of Nedd4-2 in lung epithelial cells causes progressive pulmonary fibrosis in adult mice |
| Q36802305 | Control for Population Structure and Relatedness for Binary Traits in Genetic Association Studies via Logistic Mixed Models |
| Q92510114 | Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans |
| Q92029835 | DSP variants may be associated with longitudinal change in quantitative emphysema |
| Q36916067 | Desmoplakin Variants Are Associated with Idiopathic Pulmonary Fibrosis |
| Q47102579 | Divergent roles for Clusterin in Lung Injury and Repair. |
| Q41025473 | Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias |
| Q34060344 | Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. |
| Q26849378 | Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis |
| Q44825417 | Embracing complex diseases. The case for an idiopathic pulmonary fibrosis biorepository |
| Q47239127 | Emerging roles of CST in maintaining genome stability and human disease. |
| Q47913152 | Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease |
| Q55332823 | Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease. |
| Q50044127 | Ensemble genomic analysis in human lung tissue identifies novel genes for chronic obstructive pulmonary disease. |
| Q37359126 | Epidemiology of idiopathic pulmonary fibrosis |
| Q33600748 | Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study |
| Q38346940 | Epigenetics in idiopathic pulmonary fibrosis |
| Q36119163 | Epigenetics in lung fibrosis: from pathobiology to treatment perspective |
| Q38205635 | Epigenetics of idiopathic pulmonary fibrosis |
| Q66476273 | Epigenome-wide association study for 28-day survival of acute respiratory distress syndrome |
| Q92003078 | Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease |
| Q35554660 | Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening |
| Q35153490 | Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. |
| Q34678023 | Familial Interstitial Pneumonia (FIP). |
| Q90606561 | Familial pulmonary fibrosis: a world without frontiers |
| Q51760494 | Fibrosis: Lessons from OMICS analyses of the human lung. |
| Q37564540 | Fibrotic microenvironment promotes the metastatic seeding of tumor cells via activating the fibronectin 1/secreted phosphoprotein 1-integrin signaling. |
| Q37698325 | Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report |
| Q48037972 | Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis |
| Q37400152 | Genetic architecture of human fibrotic diseases: disease risk and disease progression |
| Q38210815 | Genetic determinants of pulmonary fibrosis: evolving concepts |
| Q30274832 | Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis |
| Q104287299 | Genetic mechanisms of critical illness in Covid-19 |
| Q104439908 | Genetic mechanisms of critical illness in Covid-19 |
| Q28243802 | Genetic susceptibility and pulmonary fibrosis |
| Q36481348 | Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients |
| Q40897444 | Genetic variant near TERC influencing the risk of gliomas with older age at diagnosis in a Chinese population |
| Q46125322 | Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. |
| Q34479395 | Genetics and early detection in idiopathic pulmonary fibrosis |
| Q42367959 | Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment |
| Q35649228 | Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight). |
| Q35239965 | Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course |
| Q92148453 | Genome-Wide Association Studies in Idiopathic Pulmonary Fibrosis: Bridging the Gap between Sequence and Consequence |
| Q30252379 | Genome-wide association study of subclinical interstitial lung disease in MESA. |
| Q30388977 | Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia |
| Q37563857 | IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER. |
| Q41247286 | Identification of candidate protective variants for common diseases and evaluation of their protective potential |
| Q55238602 | Identification of periplakin as a major regulator of lung injury and repair in mice. |
| Q57170607 | Idiopathic Pulmonary Fibrosis (IPF): An Overview |
| Q93091814 | Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways |
| Q64274792 | Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets |
| Q38821078 | Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways |
| Q60496317 | Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes |
| Q87721963 | Idiopathic pulmonary fibrosis |
| Q89691744 | Idiopathic pulmonary fibrosis |
| Q90023673 | Idiopathic pulmonary fibrosis in West Highland white terriers: An update |
| Q57762744 | Idiopathic pulmonary fibrosis: An update |
| Q42109310 | Idiopathic pulmonary fibrosis: a paradigm of late-onset, single-gene human disease? |
| Q54445538 | Idiopathic pulmonary fibrosis: combating on a new turf. |
| Q50139812 | Idiopathic pulmonary fibrosis: idiopathic no more? |
| Q48129735 | Idiopathic pulmonary fibrosis: on the move. |
| Q50326794 | Idiopathic pulmonary fibrosis: pathogenesis and management. |
| Q99630566 | Immunopathobiology of chronic lung disease |
| Q35786160 | Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis |
| Q59332980 | Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis |
| Q47239342 | Insights from human genetic studies of lung and organ fibrosis |
| Q47658743 | Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis. |
| Q100317970 | Integrative genomic analysis in African American children with asthma finds three novel loci associated with lung function |
| Q52642397 | Integrative genomics identifies new genes associated with severe COPD and emphysema. |
| Q97568165 | Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society |
| Q52718368 | Is personalized medicine a realistic goal in idiopathic pulmonary fibrosis? |
| Q26998459 | Is there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies? |
| Q27301341 | Linking the genetic architecture of cytosine modifications with human complex traits |
| Q38924351 | Living with Fibrosis: From Diagnosis to Future Hope. |
| Q89582257 | Loss of Family with Sequence Similarity 13, Member A Exacerbates Pulmonary Fibrosis Potentially by Promoting Epithelial to Mesenchymal Transition |
| Q89696096 | Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition |
| Q52937788 | Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis. |
| Q39335156 | Lung Manifestations in the Rheumatic Diseases |
| Q37189462 | Lung fibrosis-associated surfactant protein A1 and C variants induce latent transforming growth factor β1 secretion in lung epithelial cells |
| Q30384494 | Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study |
| Q57808775 | MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease |
| Q42940622 | MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis. |
| Q36490141 | MUC5B and Idiopathic Pulmonary Fibrosis |
| Q36132579 | MUC5B expression and location in surfactant protein C mutations in children |
| Q90316654 | MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis |
| Q58761750 | Macrophages: friend or foe in idiopathic pulmonary fibrosis? |
| Q38981232 | Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis |
| Q29248145 | Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis |
| Q64937660 | Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells. |
| Q60923169 | Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study |
| Q38220769 | Molecular biomarkers in interstitial lung diseases. |
| Q26864836 | Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers |
| Q38243943 | Moving beyond genetics: is FAM13A a major biological contributor in lung physiology and chronic lung diseases? |
| Q90408307 | Muc5b Enhances Murine Honeycomb-like Cyst Formation |
| Q34046860 | Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males |
| Q34471193 | Nintedanib in the treatment of idiopathic pulmonary fibrosis |
| Q64957934 | Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing. |
| Q36123192 | Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank |
| Q38806251 | Numericware i: Identical by State Matrix Calculator |
| Q57101603 | OUP accepted manuscript |
| Q57289193 | Obesity-associated family with sequence similarity 13, member A (FAM13A) is dispensable for adipose development and insulin sensitivity |
| Q38222245 | Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications |
| Q34019921 | Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings |
| Q42479603 | Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis |
| Q43062778 | Personalizing Therapy in Idiopathic Pulmonary Fibrosis: A Glimpse of the Future? |
| Q38851479 | Pharmacogenetics and interstitial lung disease |
| Q29248074 | Phospholipid flippases attenuate LPS-induced TLR4 signaling by mediating endocytic retrieval of Toll-like receptor 4 |
| Q30253065 | Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis |
| Q37431872 | Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis |
| Q38832472 | Precision medicine in idiopathic pulmonary fibrosis. |
| Q91784806 | Prognostic relevance of telomere length and telomerase reverse transcriptase variant (rs2242652) on the multiple myeloma patients |
| Q37734892 | Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness. |
| Q36062197 | Proteomic Analysis of the Rat Canalicular Membrane Reveals Expression of a Complex System of P4-ATPases in Liver |
| Q38995612 | Pulmonary fibrosis in the era of stratified medicine. |
| Q40272697 | Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis |
| Q35262015 | Rare variants in RTEL1 are associated with familial interstitial pneumonia |
| Q36472166 | Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry |
| Q26745905 | Recent advances in understanding idiopathic pulmonary fibrosis |
| Q48150087 | Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis |
| Q35171019 | Regulation of nuclear-cytoplasmic shuttling and function of Family with sequence similarity 13, member A (Fam13a), by B56-containing PP2As and Akt. |
| Q35044740 | Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis |
| Q92193223 | Resequencing to Fine Map Known Idiopathic Pulmonary Fibrosis Risk Genes. Homing in on Causal Variants |
| Q27687743 | Respiratory epithelial cells orchestrate pulmonary innate immunity |
| Q35157806 | Respiratory microbiome in IPF: cause, effect, or biomarker? |
| Q50676736 | Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model. |
| Q89167691 | Reversing Mechanoinductive DSP Expression by CRISPR/dCas9-mediated Epigenome Editing |
| Q90537703 | Risk factors for the development of idiopathic pulmonary fibrosis: A review |
| Q46028356 | Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. |
| Q95355760 | Role of Microbial Agents in Pulmonary Fibrosis |
| Q39296044 | SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis. |
| Q38930521 | SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis |
| Q28386089 | Secreted Phosphoprotein 1 and Sex-Specific Differences in Silica-Induced Pulmonary Fibrosis in Mice |
| Q34692137 | Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations |
| Q91235944 | Shared and distinct mechanisms of fibrosis |
| Q88875725 | Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside |
| Q37469191 | Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. |
| Q36095068 | Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF. |
| Q38432028 | Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis |
| Q92684874 | Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events |
| Q36516894 | TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis |
| Q42580526 | Taking the "I" out of IPF. |
| Q89154468 | Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosis |
| Q27027433 | Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities |
| Q38296340 | Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis |
| Q52726708 | Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis. |
| Q37277301 | Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis |
| Q28084275 | Telomere maintenance and the etiology of adult glioma |
| Q89170883 | Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis |
| Q26795473 | The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis |
| Q47282447 | The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies |
| Q40146154 | The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study. |
| Q35041524 | The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries. |
| Q47124422 | The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes |
| Q34935466 | The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population |
| Q91910333 | The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B |
| Q26786969 | The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis |
| Q59801806 | The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis |
| Q93082066 | The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications |
| Q98190329 | The contribution of animal models to understanding the role of the immune system in human idiopathic pulmonary fibrosis |
| Q38181073 | The epithelium in idiopathic pulmonary fibrosis: breaking the barrier |
| Q38809929 | The expression of proline-specific enzymes in the human lung |
| Q35785682 | The future of the development of medicines in idiopathic pulmonary fibrosis |
| Q40777090 | The genetic basis of idiopathic pulmonary fibrosis |
| Q37342804 | The importance of detailed epigenomic profiling of different cell types within organs |
| Q38215534 | The importance of matrix metalloproteinase-3 in respiratory disorders |
| Q46825127 | The lung microbiome in idiopathic pulmonary fibrosis. What does it mean and what should we do about it? |
| Q90950675 | The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort |
| Q88129968 | The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis |
| Q33871544 | The respiratory microbiome in idiopathic pulmonary fibrosis |
| Q34986902 | The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis |
| Q39198820 | The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases |
| Q50056514 | Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? |
| Q39040828 | Tissue remodelling in pulmonary fibrosis |
| Q40463304 | Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF. |
| Q89067946 | Towards genetic reclassification of idiopathic pulmonary fibrosis |
| Q51764891 | Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease. |
| Q90628690 | Transcriptional regulatory model of fibrosis progression in the human lung |
| Q52648646 | Transcriptome analysis reveals differential splicing events in IPF lung tissue. |
| Q50074612 | Transformation of Summary Statistics from Linear Mixed Model Association on All-or-None Traits to Odds Ratio. |
| Q91622811 | Translational research in pulmonary fibrosis |
| Q39013034 | Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group |
| Q26775753 | Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review |
| Q54264691 | Tuberculosis and lung damage: from epidemiology to pathophysiology. |
| Q26779192 | Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs |
| Q49734357 | Update in Interstitial Lung Disease 2016. |
| Q35153423 | Update in diffuse parenchymal lung disease, 2013 |
| Q92030137 | Use of precision cut lung slices as a translational model for the study of lung biology |
| Q38642884 | Using omics approaches to understand pulmonary diseases |
| Q47804444 | Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis |
| Q29417088 | Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk |
| Q50241447 | What if we made stratified medicine work for patients? |
| Q64977645 | Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma. |
| Q55407487 | Whole-Exome Sequencing Insights into Adult Pulmonary Fibrosis. Repeating the Telomere Theme. |
| Q26766313 | Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease |
| Q42498214 | mTORC1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts. |
Search more.